AngioDynamics, Inc.

NasdaqGS:ANGO Stock Report

Market Cap: US$251.1m

AngioDynamics Balance Sheet Health

Financial Health criteria checks 6/6

AngioDynamics has a total shareholder equity of $218.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $324.8M and $106.1M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$78.45m
EquityUS$218.70m
Total liabilitiesUS$106.14m
Total assetsUS$324.84m

Recent financial health updates

Recent updates

A Leaner AngioDynamics Is A High-Risk Execution-Driven Story

Apr 09

AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry

Apr 06
AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry

AngioDynamics: Restructuring Initiative May Not Go Far Enough

Jan 14

AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Oct 12
AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt

Mar 31
AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt

AngioDynamics Non-GAAP EPS of -$0.06 misses by $0.04, revenue of $81.5M misses by $1.93M, reaffirms FY guidance

Oct 06

AngioDynamics: Lack Of Upside Capture Remains, Continue To Hold

Sep 29

Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?

Sep 02
Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?

AngioDynamics Non-GAAP EPS of $0.01 in-line, revenue of $87M beats by $4.09M

Jul 12

AngioDynamics Shows Progress In Still-Challenging Times

Apr 08

Is AngioDynamics (NASDAQ:ANGO) Using Debt Sensibly?

Apr 08
Is AngioDynamics (NASDAQ:ANGO) Using Debt Sensibly?

AngioDynamics - Progress Despite Margin And Pandemic Challenges

Feb 01

Does AngioDynamics (NASDAQ:ANGO) Have A Healthy Balance Sheet?

Jan 07
Does AngioDynamics (NASDAQ:ANGO) Have A Healthy Balance Sheet?

Shareholders May Not Be So Generous With AngioDynamics, Inc.'s (NASDAQ:ANGO) CEO Compensation And Here's Why

Oct 28
Shareholders May Not Be So Generous With AngioDynamics, Inc.'s (NASDAQ:ANGO) CEO Compensation And Here's Why

Is AngioDynamics (NASDAQ:ANGO) Weighed On By Its Debt Load?

Oct 07
Is AngioDynamics (NASDAQ:ANGO) Weighed On By Its Debt Load?

AngioDynamics: Focusing On Three Credible Growth Drivers And Targeting Growth Acceleration

Jul 20

Financial Position Analysis

Short Term Liabilities: ANGO's short term assets ($196.9M) exceed its short term liabilities ($85.9M).

Long Term Liabilities: ANGO's short term assets ($196.9M) exceed its long term liabilities ($20.3M).


Debt to Equity History and Analysis

Debt Level: ANGO is debt free.

Reducing Debt: ANGO has no debt compared to 5 years ago when its debt to equity ratio was 24%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ANGO has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: ANGO has sufficient cash runway for 2.3 years if free cash flow continues to reduce at historical rates of 46.4% each year.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.